celecoxib
- Manufacturer
- Central Packaging | Central Packaging, LLC
- Effective date
- 2021-02-22
- Label type
- HUMAN PRESCRIPTION DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 20:35:41
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
CONTRAINDICATIONS SECTION
Celecoxib is contraindicated in the following patients: · Known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions)to celecoxib, any components of the drug product [see Warnings and Precautions (5.7, 5.9)].· History of asthma, urticaria, or other allergic-type reactions after taking aspirin or other NSAIDs. Severe, sometimes fatal, anaphylactic reactions to NSAIDs, have been reported in such patients [see Warnings and Precautions (5.7, 5.8)]. · In the setting of coronary artery bypass graft (CABG) surgery [see Warnings and Precautions (5.1)].· In patients who have demonstrated allergic-type reactions to sulfonamides.
LABORATORY TESTS SECTION
Because serious GI bleeding, hepatotoxicity, and renal injury can occur without warning symptoms or signs, consider monitoring patients on long-term NSAID treatment with a CBC and a chemistry profile periodically [see Warnings and Precautions (5.2, 5.3, 5.6)]. In controlled clinical trials, elevated BUN occurred more frequently in patients receiving celecoxib compared with patients on placebo. This laboratory abnormality was also seen in patients who received comparator NSAIDs in these studies. The clinical significance of this abnormality has not been established.
DOSAGE FORMS & STRENGTHS SECTION
Celecoxib capsules: 50 mg are opaque white/opaque white hard gelatin capsules size “5” having imprinting “134” on body with red ink and “A” on cap with red ink filled with white to off-white colored granular powder. 100 mg are opaque white/opaque white hard gelatin capsules size “3” having imprinting “135” on body with blue ink and “A” on cap with blue ink filled with white to off-white colored granular powder. 200 mg are opaque white/opaque white hard gelatin capsules size “1” having imprinting “136” on body with golden yellow ink and “A” on cap with golden yellow ink filled with white to off-white colored granular powder. 400 mg are opaque white/opaque white hard gelatin capsules size “00” having imprinting “137” on body with green ink and “A” on cap with green ink filled with white to off-white colored granular powder.
SPL MEDGUIDE SECTION
Medication Guide
for
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
(See the end of this Medication Guide for a list of prescription NSAID medicines.)
What is the most important information I should know about medicines called Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)?
NSAID medicines may increase the chance of a heart attack or stroke that can lead to death.
This chance increases:
with longer use of NSAID medicines
in people who have heart disease
NSAID medicines should never be used right before or after a heart surgery called a "coronary artery bypass graft (CABG)."
NSAID medicines can cause ulcers and bleeding in the stomach and intestines at any time during treatment. Ulcers and bleeding:
can happen without warning symptoms
may cause death
The chance of a person getting an ulcer or bleeding increases with:
taking medicines called "corticosteroids" and "anticoagulants"
longer use
smoking
drinking alcohol
older age
having poor health
NSAID medicines should only be used:
exactly as prescribed
at the lowest dose possible for your treatment
for the shortest time needed
What are Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)?
NSAID medicines are used to treat pain and redness, swelling, and heat (inflammation) from medical conditions such as:
different types of arthritis
menstrual cramps and other types of short-term pain
Who should not take a Non-Steroidal Anti-Inflammatory Drug (NSAID)?
Do not take an NSAID medicine:
if you had an asthma attack, hives, or other allergic reaction with aspirin or any other NSAID medicine
for pain right before or after heart bypass surgery
Tell your healthcare provider:
about all of your medical conditions.
about all of the medicines you take. NSAIDs and some other medicines can interact with each other and cause serious side effects. Keep a list of your medicines to show to your healthcare provider and pharmacist.
if you are pregnant. NSAID medicines should not be used by pregnant women late in their pregnancy.
if you are breastfeeding. Talk to your doctor.
What are the possible side effects of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)?
Serious side effects include: Other side effects include:
heart attack
stroke
high blood pressure
heart failure from body swelling (fluid retention)
kidney problems including kidney failure
bleeding and ulcers in the stomach and intestine
low red blood cells (anemia)
life-threatening skin reactions
life-threatening allergic reactions
liver problems including liver failure
asthma attacks in people who have asthma
stomach pain
constipation
diarrhea
gas
heartburn
nausea
vomiting
dizziness
Get emergency help right away if you have any of the following symptoms:
shortness of breath or trouble breathing
chest pain
weakness in one part or side of your body
slurred speech
swelling of the face or throat
Stop your NSAID medicine and call your healthcare provider right away if you have any of the following symptoms:
nausea
more tired or weaker than usual
itching
your skin or eyes look yellow
stomach pain
flu-like symptoms
vomit blood
there is blood in your bowel movement or it is black and sticky like tar
skin rash or blisters with fever
unusual weight gain
swelling of the arms and legs, hands and feet
These are not all the side effects with NSAID medicines. Talk to your healthcare provider or pharmacist for more information about NSAID medicines.
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Other information about Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
Aspirin is an NSAID medicine but it does not increase the chance of a heart attack. Aspirin can cause bleeding in the brain, stomach, and intestines. Aspirin can also cause ulcers in the stomach and intestines.
Some of these NSAID medicines are sold in lower doses without a prescription (over –the –counter). Talk to your healthcare provider before using over –the –counter NSAIDs for more than 10 days.
NSAID medicines that need a prescription
Generic Name Tradename
*Vicoprofen contains the same dose of ibuprofen as over-the-counter (OTC) NSAIDs, and is usually used for less than 10 days to treat pain. The OTC NSAID label warns that long term continuous use may increase the risk of heart attack or stroke.
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed RxNorm Mappings#
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| CELECOXIB Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20191108 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| bff1fbab-f4cc-4993-b7de-2b555ee5eb73 | Product name | 1 | 20220509 |
| cc117a7e-1ef6-4866-90a7-ce0d190eef9a | Product name | 1 | 20200925 |
| 827beb42-45f2-95b8-6aa3-f35174375422 | Product name | 9 | 20160429 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80175-0142-3 | celecoxib | 30 in 1 BOTTLE | CAPSULE | 30 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80175-0142 | CELECOXIB CAPSULE [CENTRAL PACKAGING] | 1 | Legacy NDC, 1 package rows | 20210225_bbf509e1-a8c2-56b8-e053-2995a90ae5c7.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 62332-142-31 | EA - Each | 62332-142 | 38733a71-8277-4144-aee3-da6296916a76 | 1 | 2016-02-04 |
| 62332-142-71 | EA - Each | 62332-142 | df45db2f-2a08-4f10-9514-dfa5248b1d98 | 1 | 2017-06-15 |
| 62332-142-91 | EA - Each | 62332-142 | 8c3f2a98-3c9b-4d87-acfd-25e89ccf47e6 | 1 | 2016-06-14 |
Products#
Every source-derived product name is available through these pages.
- celecoxib
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 80175-0142 | 80175-0142-3 |
| 62332-142 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CELECOXIB | JCX84Q7J1L | ACTIB |
Source Document#
Orange Book application contexts#
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A204519-001 | CELECOXIB | CELECOXIB | 50MG | CAPSULE / ORAL | AB | 2015-08-21 | |
| A204519-002 | CELECOXIB | CELECOXIB | 100MG | CAPSULE / ORAL | AB | 2015-08-21 | |
| A204519-003 | CELECOXIB | CELECOXIB | 200MG | CAPSULE / ORAL | AB | 2015-08-21 | |
| A204519-004 | CELECOXIB | CELECOXIB | 400MG | CAPSULE / ORAL | AB | 2015-08-21 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A204519-001 | AB |
| A204519-002 | AB |
| A204519-003 | AB |
| A204519-004 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A204519-001 | CELECOXIB | 50MG | CAPSULE / ORAL | AB | 2015-08-21 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A204519-002 | CELECOXIB | 100MG | CAPSULE / ORAL | AB | 2015-08-21 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A204519-003 | CELECOXIB | 200MG | CAPSULE / ORAL | AB | 2015-08-21 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A204519-004 | CELECOXIB | 400MG | CAPSULE / ORAL | AB | 2015-08-21 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A204519-001 | CELECOXIB | 50MG | CAPSULE / ORAL | AB | 2015-08-21 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A204519-002 | CELECOXIB | 100MG | CAPSULE / ORAL | AB | 2015-08-21 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A204519-003 | CELECOXIB | 200MG | CAPSULE / ORAL | AB | 2015-08-21 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A204519-004 | CELECOXIB | 400MG | CAPSULE / ORAL | AB | 2015-08-21 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A204519-001 | CELECOXIB | 50MG | CAPSULE / ORAL | AB | 2015-08-21 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A204519-002 | CELECOXIB | 100MG | CAPSULE / ORAL | AB | 2015-08-21 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A204519-003 | CELECOXIB | 200MG | CAPSULE / ORAL | AB | 2015-08-21 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A204519-004 | CELECOXIB | 400MG | CAPSULE / ORAL | AB | 2015-08-21 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A204519-001 | CELECOXIB | 50MG | CAPSULE / ORAL | AB | 2015-08-21 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A204519-002 | CELECOXIB | 100MG | CAPSULE / ORAL | AB | 2015-08-21 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A204519-003 | CELECOXIB | 200MG | CAPSULE / ORAL | AB | 2015-08-21 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A204519-004 | CELECOXIB | 400MG | CAPSULE / ORAL | AB | 2015-08-21 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A204519-001 | CELECOXIB | 50MG | CAPSULE / ORAL | AB | 2015-08-21 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A204519-002 | CELECOXIB | 100MG | CAPSULE / ORAL | AB | 2015-08-21 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A204519-003 | CELECOXIB | 200MG | CAPSULE / ORAL | AB | 2015-08-21 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A204519-004 | CELECOXIB | 400MG | CAPSULE / ORAL | AB | 2015-08-21 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A204519-001 | CELECOXIB | 50MG | CAPSULE / ORAL | AB | 2015-08-21 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A204519-002 | CELECOXIB | 100MG | CAPSULE / ORAL | AB | 2015-08-21 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A204519-003 | CELECOXIB | 200MG | CAPSULE / ORAL | AB | 2015-08-21 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A204519-004 | CELECOXIB | 400MG | CAPSULE / ORAL | AB | 2015-08-21 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A204519-001 | CELECOXIB | 50MG | CAPSULE / ORAL | AB | 2015-08-21 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A204519-002 | CELECOXIB | 100MG | CAPSULE / ORAL | AB | 2015-08-21 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A204519-003 | CELECOXIB | 200MG | CAPSULE / ORAL | AB | 2015-08-21 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A204519-004 | CELECOXIB | 400MG | CAPSULE / ORAL | AB | 2015-08-21 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A204519-001 | CELECOXIB | 50MG | CAPSULE / ORAL | AB | 2015-08-21 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A204519-002 | CELECOXIB | 100MG | CAPSULE / ORAL | AB | 2015-08-21 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A204519-003 | CELECOXIB | 200MG | CAPSULE / ORAL | AB | 2015-08-21 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A204519-004 | CELECOXIB | 400MG | CAPSULE / ORAL | AB | 2015-08-21 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A204519-001 | CELECOXIB | 50MG | CAPSULE / ORAL | AB | 2015-08-21 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A204519-002 | CELECOXIB | 100MG | CAPSULE / ORAL | AB | 2015-08-21 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A204519-003 | CELECOXIB | 200MG | CAPSULE / ORAL | AB | 2015-08-21 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A204519-004 | CELECOXIB | 400MG | CAPSULE / ORAL | AB | 2015-08-21 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A204519-001 | CELECOXIB | 50MG | CAPSULE / ORAL | AB | 2015-08-21 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A204519-002 | CELECOXIB | 100MG | CAPSULE / ORAL | AB | 2015-08-21 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A204519-003 | CELECOXIB | 200MG | CAPSULE / ORAL | AB | 2015-08-21 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A204519-004 | CELECOXIB | 400MG | CAPSULE / ORAL | AB | 2015-08-21 | 5bbf6a4d5a75… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A204519-001 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A204519-002 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A204519-003 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A204519-004 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A204519-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A204519-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A204519-003 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A204519-004 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A204519-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A204519-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A204519-003 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A204519-004 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A204519-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A204519-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A204519-003 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A204519-004 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A204519-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A204519-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A204519-003 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A204519-004 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A204519-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A204519-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A204519-003 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A204519-004 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A204519-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A204519-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A204519-003 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A204519-004 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A204519-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A204519-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A204519-003 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A204519-004 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A204519-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A204519-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A204519-003 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A204519-004 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A204519-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A204519-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A204519-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A204519-004 | AB | 1 | 5bbf6a4d5a75… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Celecoxib | CELECOXIB | Alembic Pharmaceuticals Inc. | 806e5f8a-f986-4f88-ba3e-8265f86afa48 | 2026-07-31 | Boxed warning, Warnings, Adverse reactions | 62332-142 |
| bbf51dac-5ad0-54b8-e053-2995a90aa71c | bbf509e1-a8c2-56b8-e053-2995a90ae5c7 | 2021-02-22 | bbf51dac-5ad0-54b8-e053-2995a90aa71c bbf509e1-a8c2-56b8-e053-2995a90ae5c7 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
